Skip to content

On the plains of Africa you’ll find a surprising cooperation between two typically adversarial animals—the drongo bird and the meerkat. What makes the relationship especially vexing is that they both covet the same food. But instead of being fierce adversaries, they maintain a symbiotic partnership. When predators to the meerkat are in the vicinity, the drongo bird will give out a warning cry, alerting the spirited mammals of the danger. The meerkats quickly scurry back to their burrows, and in their haste often drop a bit of food. The drongo swoops in and grabs the free meal, while the meerkat huddles in his hole avoiding the predator. A win-win.  

In a similar manner (albeit generally not on the plains of Africa), the relationship between broadly syndicated loans (BSL) and direct lending (DL) could be considered more symbiotic than adversarial as well. While in recent months the media has presented it as an either-or situation, with headlines like “Private credit’s golden era may face strain amid a resurgence in the BSL market,”1 it is not necessarily so binary. In many instances borrowers can have their BSL cake and eat DL as well.

Increased deal flow—a win for credit investors

As banks increase their risk appetite, which they have in recent months given the strong macroeconomic backdrop, they will start putting more capital into the market in the form of BSL commitments. This bank action in some ways acts as a lubricant for the merger-and-acquisition (M&A) machine. The animal spirits come back and the pie grows. While DL may lose some share of the market to BSL as a result, in my experience there are enough deals with enough spread to keep both the drongo fat and the meerkat happy (Exhibit 1).

Exhibit 1: The Deal Pie Is Bigger

New-Issue Volume for Deals Financing LBOs
Data through March 18, 2024

Source: PitchBook | LCD • Data through March 18, 2024.
Direct lending analysis is based on transactions covered by LCD News

Any competition between BSL and DL, when it does occur, tends to happen in the upper middle market—companies with EBITDA2 >US$100 million. Direct lenders in that portion of the market may lose some market share and see spreads compressed. However, the core middle market—companies with EBITDA between US$25 million-US$100 million—will still benefit from increased deal flow, as financial sponsors (the lifeblood of this segment) get more comfortable doing deals after a period of dormancy. It is still a win-win. Business media outlets like Bloomberg and others tend to underreport these middle-market transactions, because they lack the sensational value of a US$1 billion+ headline. These under the radar transactions are where alpha may be captured. For example, the core middle market still has a healthy, albeit diminished, illiquidity premium. In contrast, the upper middle market has seen its illiquidity premium over syndicated deals get squeezed significantly.

The bottom line is that it doesn’t have to be a binary selection between BSL or DL debt for allocators—there are opportunities in both. We see in Exhibit 2 that private credit deals continued to grow in number over the first quarter of 2024.     

Exhibit 2: Direct Lending Is not Going Away

Count of LBOs Financed in BSL vs. Private Credit Market
Data through March 18, 2024

 

Source: Source: PitchBook | LCD • Data through March 18, 2024
Private credit count is based on transactions covered by LCD News

The symbiotic relationship between BSL and DL is even more direct in some situations. More recently we are seeing deals that have both a BSL and DL structure. For example, in February of this year Ardonaugh Group Ltd.3 recapitalized its business with both DL and BSL components in the financing.

This practice isn’t abnormal. For many years, the typical LBO would have a first lien BSL component provided by collateralized loan obligations (CLOs), and a junior second-lien component provided by direct lending firms. Eventually lines got blurred and these structures became blended unitranche deals, where everyone was competing for the same pie. Today we're seeing a return of second-lien deals, such as the financing to support the leveraged buyout of Truist Financial Corp.’s insurance business.4 In my view, this practice is a better way of slicing the pie—the risk gets allocated appropriately. Those who want lower risk (BSL lenders) get the lower risk senior debt (first lien), and those seeking higher spread get the second-lien junior debt.  

Not always win-win: Covenant-lite growth may be warning sign

While both BSL and DL can coexist in the same market, there can be a downside to increased competition between the two debt structures. When markets get more competitive in the upper- middle-market segment, we often begin to see more risk-taking. Symptoms of froth, such as a lack of financial maintenance covenants (cov-lite) in documents, may become more frequent in DL structures. This should be the exception not the norm. This heightened risk can spread to the core middle market as well, which is not fully immune from these trends despite being more sheltered from competition. 

In conclusion, increased activity in the BSL space is not necessarily a bad thing for DL, and vice versa. They can coexist and even complement each other, providing a variety of financing options for different risk appetites. It is not an either/or condition, it is both/and. Even birds and cats get along sometimes.



Important Legal Information

This document is for information only and does not constitute investment advice or a recommendation and was prepared without regard to the specific objectives, financial situation or needs of any particular person who may receive it. This document may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

Any research and analysis contained in this document has been procured by Franklin Templeton for its own purposes and may be acted upon in that connection and, as such, is provided to you incidentally. Although information has been obtained from sources that Franklin Templeton believes to be reliable, no guarantee can be given as to its accuracy and such information may be incomplete or condensed and may be subject to change at any time without notice. Any views expressed are the views of the fund manager as of the date of this document and do not constitute investment advice. The underlying assumptions and these views are subject to change based on market and other conditions and may differ from other portfolio managers or of the firm as a whole. 

There is no assurance that any prediction, projection or forecast on the economy, stock market, bond market or the economic trends of the markets will be realized. Franklin Templeton accepts no liability whatsoever for any direct or indirect consequential loss arising from the use of any information, opinion or estimate herein.

The value of investments and the income from them can go down as well as up and you may not get back the full amount that you invested. Past performance is not necessarily indicative nor a guarantee of future performance.

Copyright© 2025 Franklin Templeton. All rights reserved. Issued by Templeton Asset Management Ltd. Registration Number (UEN) 199205211E.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.